medroxyprogesterone acetate has been researched along with Inflammation in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 10 (40.00) | 29.6817 |
| 2010's | 10 (40.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Ahmed, K; Bailey, V; Beksinska, M; Buck, G; Chen, PL; Deese, J; Gao, X; Harryparsad, R; Lefebvre d'Hellencourt, F; Masson, L; Mehou-Loko, C; Meyer, B; Morrison, C; Nanda, K; Radzey, N; Serrano, M; Smit, J; Strauss, J; Taku, O; Williamson, AL | 1 |
| Balle, C; Bosinger, SE; Burgener, AD; Dabee, S; Happel, AU; Heffron, R; Innes, S; Jaspan, H; Nair, G; Onono, M; Palanee-Phillips, T; Passmore, JS | 1 |
| Bersinger, NA; Facchinetti, F; Grandi, G; McKinnon, BD; Mueller, MD | 1 |
| Dizzell, S; Kaushic, C; Verschoor, CP; Woods, MW; Zahoor, MA | 1 |
| Barkley, MS; Kullolli, O; Logiodice, F; Lombardelli, L; Maggi, E; Piccinni, MP | 1 |
| Chen, PL; Chipato, T; Doncel, GF; Fichorova, RN; Kwok, C; Mauck, C; Morrison, C; Salata, R | 1 |
| Africander, D; Hapgood, JP; Louw-du Toit, R | 1 |
| Abdellati, S; Agot, K; Ahmed, K; Cohen, M; Crucitti, T; Deese, J; Masson, L; Miller, W; Morrison, C; Van Damme, L; Wang, M | 1 |
| Aweeka, F; Bosch, R; Cho, A; Cohn, SE; Cramer, Y; Livingston, E; Luque, AE; Park, JG; Watts, DH; Weinberg, A | 1 |
| Bersinger, N; Cagnacci, A; Grandi, G; McKinnon, B; Mueller, M; Nirgianakis, K; Papadia, A | 1 |
| Ebner, CA; Elovitz, MA; Yellon, SM | 1 |
| Collins, JJ; Gavilanes, AW; Ikegami, M; Jobe, AH; Kallapur, SG; Kemp, MW; Kramer, BW; Kuypers, E; Newnham, JP; Nitsos, I; Nowacki, R; Ofman, G; Pillow, JJ; Polglase, GR | 1 |
| Ahn, JY; Choi, IS; Jin, DK; Kim, DS; Kim, HS; Koh, KK; Shin, EK; Shin, MS; Son, JW; Yoon, BK | 1 |
| Rachoń, D | 1 |
| Fini, M; Gebara, O; Leonardo, F; Mercuro, G; Ramires, JA; Rosano, GM; Silvestri, A; Vitale, C; Wajngarten, M | 1 |
| Elovitz, M; Wang, Z | 1 |
| Alderman, EL; Howard, BV; Hsia, J; Lindsay, J; Ouyang, P; Silverman, A; Tripputi, M; Van Voorhees, L; Waters, DD | 1 |
| Barrett-Connor, E; Greendale, GA; Herrington, DM; Hu, P; Palla, SL; Reboussin, BA; Reuben, DB | 1 |
| Elovitz, MA; Mrinalini, C | 1 |
| Blumenfeld, Z; Boulman, N; Leiba, R; Levy, Y; Linn, R; Shachar, S; Siegler, E | 1 |
| Elovitz, MA; Gonzalez, J | 1 |
| Amortegui, AJ; Blander, SJ | 1 |
| Barrett-Connor, E; Cushman, M; Judd, HL; Kessler, C; Legault, C; Sakkinen, PA; Stefanick, ML; Tracy, RP | 1 |
| Asaishi, K; Hirata, K; Narimatsu, E; Okazaki, A; Okazaki, M; Okazaki, Y; Sato, H; Toda, K; Watanabe, Y; Yamada, T | 1 |
1 review(s) available for medroxyprogesterone acetate and Inflammation
| Article | Year |
|---|---|
Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections.
Topics: Bacteria; Contraceptive Agents, Female; Female; HIV Infections; Humans; Inflammation; Medroxyprogesterone Acetate; Mucous Membrane; Observational Studies as Topic | 2023 |
7 trial(s) available for medroxyprogesterone acetate and Inflammation
| Article | Year |
|---|---|
Genital inflammatory status and the innate immune response to contraceptive initiation.
Topics: Contraceptive Agents, Female; Cytokines; Female; Genitalia; HIV Infections; Humans; Immunity, Innate; Inflammation; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate | 2022 |
Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.
Topics: Adolescent; Adult; Biomarkers; Contraceptive Agents, Female; Delayed-Action Preparations; Female; HIV Infections; Humans; Immunity, Cellular; Inflammation; Injections, Intramuscular; Lymphocyte Activation; Medroxyprogesterone Acetate; Middle Aged; T-Lymphocytes, Regulatory; Young Adult | 2016 |
Effects of continuous combined hormone replacement therapy on inflammation in hypertensive and/or overweight postmenopausal women.
Topics: Animals; Biomarkers; Brachial Artery; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Horses; Humans; Hypertension; Inflammation; Lipids; Medroxyprogesterone Acetate; Middle Aged; Obesity; Postmenopause; Progesterone; Progesterone Congeners; Regional Blood Flow; Vasomotor System | 2002 |
Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
Topics: Administration, Oral; Biomarkers; C-Reactive Protein; Complement C3; Complement C4; E-Selectin; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Liver; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Thrombomodulin; Time; Vascular Cell Adhesion Molecule-1 | 2003 |
Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance.
Topics: Adult; Aged; Blood Glucose; C-Reactive Protein; Canada; Comorbidity; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Disease Progression; Drug Combinations; Estrogens, Conjugated (USP); Female; Fibrinogen; Follow-Up Studies; Glucose Intolerance; Hormone Replacement Therapy; Humans; Hysterectomy; Inflammation; Insulin; Insulin Resistance; Lipoproteins, HDL; Medroxyprogesterone Acetate; Middle Aged; Obesity; Postmenopause; Prospective Studies; Single-Blind Method; Triglycerides; United States | 2004 |
The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial.
Topics: C-Reactive Protein; Double-Blind Method; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone | 2006 |
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study.
Topics: Antigens; Biomarkers; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Double-Blind Method; E-Selectin; Estrogens, Conjugated (USP); Factor VIII; Female; Hormone Replacement Therapy; Humans; Inflammation; Lipids; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone; Risk Factors; Smoking; Treatment Outcome; von Willebrand Factor | 1999 |
17 other study(ies) available for medroxyprogesterone acetate and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
Topics: Adult; Cytokines; Endometriosis; Endometrium; Female; Humans; Inflammation; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progestins; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Steroid; Stromal Cells; Tumor Necrosis Factor-alpha | 2017 |
Medroxyprogesterone acetate-treated human, primary endometrial epithelial cells reveal unique gene expression signature linked to innate immunity and HIV-1 susceptibility.
Topics: Adult; Cells, Cultured; Cholesterol; Contraceptive Agents, Female; Disease Susceptibility; Epithelial Cells; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Immunity, Innate; Inflammation; Medroxyprogesterone Acetate; Middle Aged; Mucous Membrane; Primary Cell Culture; Progesterone; Progestins; Tissue Array Analysis; Transcriptome | 2018 |
Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease.
Topics: Adult; Bacterial Infections; Basic Helix-Loop-Helix Transcription Factors; Cytokines; Disease Susceptibility; Female; Humans; Inflammation; Macrophages; Male; Medroxyprogesterone Acetate; Nuclear Receptor Subfamily 1, Group F, Member 3; Receptors, Aryl Hydrocarbon; Sex Factors; Signal Transduction; T-Box Domain Proteins; Th1 Cells; Th17 Cells; Virus Diseases | 2019 |
Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion.
Topics: Adolescent; Adult; Case-Control Studies; Cervix Uteri; Chemokine CCL20; Chemokine CCL5; Contraceptive Agents, Female; Cytokines; Female; HIV Seropositivity; Humans; Immunity, Innate; Inflammation; Medroxyprogesterone Acetate; Pregnancy; Prospective Studies; Risk Factors; Secretory Leukocyte Peptidase Inhibitor; Uganda; Young Adult; Zimbabwe | 2014 |
Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent manner.
Topics: CCAAT-Enhancer-Binding Protein-beta; Cell Line; Cervix Uteri; Contraceptive Agents, Female; Epithelial Cells; Female; Gene Expression Regulation; Genomics; Humans; Inflammation; Interleukin-10; Interleukin-12 Subunit p35; Interleukin-12 Subunit p40; Medroxyprogesterone Acetate; NF-kappa B; Progestins; Receptors, Glucocorticoid; RNA, Small Interfering; STAT3 Transcription Factor | 2014 |
Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Cross-Sectional Studies; Cytokines; Female; Genitalia, Female; HIV Infections; Humans; Inflammation; Kenya; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Sexually Transmitted Diseases, Bacterial; South Africa; Vaginosis, Bacterial; Young Adult | 2015 |
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells.
Topics: Cell Proliferation; Cell Survival; Cells, Cultured; Cellular Microenvironment; Cytokines; Endometriosis; Endometrium; Estrogens; Female; Humans; Immunosuppression Therapy; Inflammation; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progestins; Stromal Cells; Tumor Necrosis Factor-alpha | 2016 |
Medroxyprogesterone acetate modulates remodeling, immune cell census, and nerve fibers in the cervix of a mouse model for inflammation-induced preterm birth.
Topics: Animals; Cervical Ripening; Cervix Uteri; Collagen; Disease Models, Animal; Female; Gestational Age; Inflammation; Injections, Intramuscular; Lipopolysaccharides; Macrophages; Medroxyprogesterone Acetate; Mice; Nerve Fibers; Neutrophil Infiltration; Pregnancy; Premature Birth; Progestins | 2009 |
Intra-amniotic LPS and antenatal betamethasone: inflammation and maturation in preterm lamb lungs.
Topics: Amnion; Animals; Betamethasone; Bronchoalveolar Lavage Fluid; Chorioamnionitis; Cytokines; Female; Fetal Development; Fetal Organ Maturity; Gene Expression; Glucocorticoids; Inflammation; Lipopolysaccharides; Lung; Male; Medroxyprogesterone Acetate; Peroxidase; Phosphatidylcholines; Pregnancy; Premature Birth; Pulmonary Surfactant-Associated Protein C; Pulmonary Surfactant-Associated Protein D; Random Allocation; Sheep; Toll-Like Receptors | 2012 |
The antiinflammatory properties of medroxyprogesterone acetate.
Topics: Administration, Oral; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Cell Adhesion Molecules; Drug Antagonism; Drug Therapy, Combination; E-Selectin; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Inflammation; Medroxyprogesterone Acetate; Postmenopause; Serum Amyloid A Protein; Structure-Activity Relationship | 2002 |
Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise.
Topics: Animals; Cervical Ripening; Contractile Proteins; Down-Regulation; Drug Synergism; Female; Fetal Death; Inflammation; Inflammation Mediators; Lipopolysaccharides; Medroxyprogesterone Acetate; Mice; Obstetric Labor, Premature; Parturition; Pregnancy; Progesterone; Receptors, Progesterone; Up-Regulation; Uterine Diseases | 2004 |
Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation?
Topics: Animals; Blotting, Western; Cervix Uteri; Female; Inflammation; Lipopolysaccharides; Medroxyprogesterone Acetate; Membrane Glycoproteins; Mice; Mice, Inbred Strains; Placenta; Pregnancy; Premature Birth; Random Allocation; Receptors, Cell Surface; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; Toll-Like Receptor 2; Toll-Like Receptor 4; Toll-Like Receptors; Uterus | 2005 |
High C-reactive protein levels are associated with oral hormonal menopausal therapy but not with intrauterine levonorgestrel and transdermal estradiol.
Topics: Administration, Cutaneous; Administration, Oral; Analysis of Variance; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Drug Administration Routes; Estradiol; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Inflammation; Intrauterine Devices, Medicated; Levonorgestrel; Lipids; Medroxyprogesterone Acetate; Menopause; Middle Aged; Risk Factors | 2007 |
Medroxyprogesterone acetate modulates the immune response in the uterus, cervix and placenta in a mouse model of preterm birth.
Topics: Animals; Anti-Infective Agents, Local; Cervix Uteri; Cytokines; Disease Models, Animal; Female; Immunity, Cellular; Inflammation; Medroxyprogesterone Acetate; Mice; Placenta; Premature Birth | 2008 |
Mice immunized with a chlamydial extract have no increase in early protective immunity despite increased inflammation following genital infection by the mouse pneumonitis agent of Chlamydia trachomatis.
Topics: Animals; Chlamydia Infections; Chlamydia trachomatis; Female; Genital Diseases, Female; Hypersensitivity, Delayed; Immunization; Inflammation; Lymphocyte Activation; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C | 1994 |
[A case of inflammatory breast cancer treated with medroxyprogesterone acetate (MPA) in combination with intra-arterial infusion chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Female; Humans; Inflammation; Infusions, Intra-Arterial; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged | 1992 |